Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study

Rheumatoid arthritis (RA) is characterized by inflammation and an increased risk for cardiovascular disease (CVD). This study investigates possible associations between CVD and the use of conventional disease-modifying antirheumatic drugs (DMARDs) in RA. Using a case control design, 613 RA patients...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: van Halm, Vokko P, Nurmohamed, Michael T, Twisk, Jos WR, Dijkmans, Ben AC, Voskuyl, Alexandre E
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2006
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1779436/
https://ncbi.nlm.nih.gov/pubmed/16984661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar2045
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars